MARKET

MRNA

MRNA

Moderna
NASDAQ
29.47
-0.45
-1.50%
Opening 13:35 12/16 EST
OPEN
29.91
PREV CLOSE
29.92
HIGH
29.92
LOW
29.04
VOLUME
3.71M
TURNOVER
--
52 WEEK HIGH
48.92
52 WEEK LOW
22.28
MARKET CAP
11.51B
P/E (TTM)
-3.6615
1D
5D
1M
3M
1Y
5Y
1D
Generation Bio price target lowered to $5.50 from $7 at Wedbush
TipRanks · 8h ago
Director’s Major Stock Sale at Moderna!
TipRanks · 20h ago
FDA Commissioner Makary says 'black box' warning not coming to COVID vaccines
Seeking Alpha · 1d ago
UPDATE 2-FDA has no plans to put most serious warning on COVID vaccines, Bloomberg News reports
Reuters · 1d ago
'FDA Chief Says No Plans To Put Boxed Warning On Covid Vaccines' - Bloomberg News
Benzinga · 1d ago
Moderna (MRNA) Is Up 5.3% After EU Panel Backs Next-Gen COVID Shot mNEXSPIKE - What's Changed
Simply Wall St · 1d ago
Option traders moderately bearish in Moderna with shares down 0.41%
TipRanks · 1d ago
Director Noubar Afeyan Reports Disposal of Moderna Inc. Common Shares
Reuters · 1d ago
More
About MRNA
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. The Company’s diverse development pipeline consists of 44 therapeutic and vaccine programs, 11 of which are in late-stage development. Its commercial products include Spikevax (its COVID vaccine) and mRESVIA (its respiratory syncytial virus (RSV) vaccine). Additionally, it has achieved four positive Phase III data readouts for its COVID vaccine (mRNA-1283), its RSV vaccine for high-risk adults aged 18 to 59 (mRNA-1345), its seasonal flu+COVID vaccine (mRNA-1083), and its seasonal flu vaccine (mRNA-1010).

Webull offers Moderna Inc stock information, including NASDAQ: MRNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MRNA stock methods without spending real money on the virtual paper trading platform.